Specifically, the relative lengthening of the transcript isoforms encoding GNB1, a critical modulator of various transmembrane signalling pathways48, is significantly associated with a better clinical outcome in neuroblastoma patients (Fig. 6c). This evidence concerns the gene GNB1 and neuroblastoma.